126 related articles for article (PubMed ID: 32820486)
21. Interaction of factor IXa with factor VIIIa. Effects of protease domain Ca2+ binding site, proteolysis in the autolysis loop, phospholipid, and factor X.
Mathur A; Zhong D; Sabharwal AK; Smith KJ; Bajaj SP
J Biol Chem; 1997 Sep; 272(37):23418-26. PubMed ID: 9287357
[TBL] [Abstract][Full Text] [Related]
22. Molecular recognition in the activation of human blood coagulation factor X.
Chattopadhyay A; Fair DS
J Biol Chem; 1989 Jul; 264(19):11035-43. PubMed ID: 2500433
[TBL] [Abstract][Full Text] [Related]
23. Thrombin-activable factor X re-establishes an intrinsic amplification in tenase-deficient plasmas.
Louvain-Quintard VB; Bianchini EP; Calmel-Tareau C; Tagzirt M; Le Bonniec BF
J Biol Chem; 2005 Dec; 280(50):41352-9. PubMed ID: 16207719
[TBL] [Abstract][Full Text] [Related]
24. Asymmetric processing of mutant factor X Arg386Cys reveals differences between intrinsic and extrinsic pathway activation.
Baroni M; Pavani G; Pinotti M; Branchini A; Bernardi F; Camire RM
Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1351-6. PubMed ID: 26012870
[TBL] [Abstract][Full Text] [Related]
25. Crystal structure of the prothrombinase complex from the venom of Pseudonaja textilis.
Lechtenberg BC; Murray-Rust TA; Johnson DJ; Adams TE; Krishnaswamy S; Camire RM; Huntington JA
Blood; 2013 Oct; 122(16):2777-83. PubMed ID: 23869089
[TBL] [Abstract][Full Text] [Related]
26. Population divergence in venom bioactivities of elapid snake Pseudonaja textilis: role of procoagulant proteins in rapid rodent prey incapacitation.
Skejić J; Hodgson WC
PLoS One; 2013; 8(5):e63988. PubMed ID: 23691135
[TBL] [Abstract][Full Text] [Related]
27. The regulation of clotting factors.
Kalafatis M; Egan JO; van 't Veer C; Cawthern KM; Mann KG
Crit Rev Eukaryot Gene Expr; 1997; 7(3):241-80. PubMed ID: 9399073
[TBL] [Abstract][Full Text] [Related]
28. Binding studies of the enzyme (factor IXa) with the cofactor (factor VIIIa) in the assembly of factor-X activating complex on the activated platelet surface.
Ahmad SS; London FS; Walsh PN
J Thromb Haemost; 2003 Nov; 1(11):2348-55. PubMed ID: 14629468
[TBL] [Abstract][Full Text] [Related]
29. Interactions between residues 2228-2240 within factor VIIIa C2 domain and factor IXa Gla domain contribute to propagation of clot formation.
Soeda T; Nogami K; Ogiwara K; Shima M
Thromb Haemost; 2011 Nov; 106(5):893-900. PubMed ID: 21947241
[TBL] [Abstract][Full Text] [Related]
30. Hemextin AB complex, a unique anticoagulant protein complex from Hemachatus haemachatus (African Ringhals cobra) venom that inhibits clot initiation and factor VIIa activity.
Banerjee Y; Mizuguchi J; Iwanaga S; Kini RM
J Biol Chem; 2005 Dec; 280(52):42601-11. PubMed ID: 16204244
[TBL] [Abstract][Full Text] [Related]
31. Structural integrity of the gamma-carboxyglutamic acid domain of human blood coagulation factor IXa Is required for its binding to cofactor VIIIa.
Larson PJ; Stanfield-Oakley SA; VanDusen WJ; Kasper CK; Smith KJ; Monroe DM; High KA
J Biol Chem; 1996 Feb; 271(7):3869-76. PubMed ID: 8632006
[TBL] [Abstract][Full Text] [Related]
32. The factor VIIIa C2 domain (residues 2228-2240) interacts with the factor IXa Gla domain in the factor Xase complex.
Soeda T; Nogami K; Nishiya K; Takeyama M; Ogiwara K; Sakata Y; Yoshioka A; Shima M
J Biol Chem; 2009 Feb; 284(6):3379-88. PubMed ID: 19047063
[TBL] [Abstract][Full Text] [Related]
33. Crystal structure of textilinin-1, a Kunitz-type serine protease inhibitor from the venom of the Australian common brown snake (Pseudonaja textilis).
Millers EK; Trabi M; Masci PP; Lavin MF; de Jersey J; Guddat LW
FEBS J; 2009 Jun; 276(11):3163-75. PubMed ID: 19490116
[TBL] [Abstract][Full Text] [Related]
34. The catalytic subunit of pseutarin C, a group C prothrombin activator from the venom of Pseudonaja textilis, is structurally similar to mammalian blood coagulation factor Xa.
Rao VS; Swarup S; Manjunatha Kini R
Thromb Haemost; 2004 Sep; 92(3):509-21. PubMed ID: 15351847
[TBL] [Abstract][Full Text] [Related]
35. Endogenous thrombin potential as a novel method for the characterization of procoagulant snake venoms and the efficacy of antivenom.
Isbister GK; Woods D; Alley S; O'Leary MA; Seldon M; Lincz LF
Toxicon; 2010 Aug; 56(1):75-85. PubMed ID: 20338189
[TBL] [Abstract][Full Text] [Related]
36. Zymogenic and enzymatic properties of the 70-80 loop mutants of factor X/Xa.
Chen L; Manithody C; Yang L; Rezaie AR
Protein Sci; 2004 Feb; 13(2):431-42. PubMed ID: 14739327
[TBL] [Abstract][Full Text] [Related]
37. Role of the Gla and first epidermal growth factor-like domains of factor X in the prothrombinase and tissue factor-factor VIIa complexes.
Thiec F; Cherel G; Christophe OD
J Biol Chem; 2003 Mar; 278(12):10393-9. PubMed ID: 12529356
[TBL] [Abstract][Full Text] [Related]
38. Substrate delivery mechanism and the role of membrane curvature in factor X activation by extrinsic tenase.
Kovalenko TA; Panteleev MA; Sveshnikova AN
J Theor Biol; 2017 Dec; 435():125-133. PubMed ID: 28935233
[TBL] [Abstract][Full Text] [Related]
39. Exactin: A specific inhibitor of Factor X activation by extrinsic tenase complex from the venom of Hemachatus haemachatus.
Girish VM; Kini RM
Sci Rep; 2016 Aug; 6():32036. PubMed ID: 27558950
[TBL] [Abstract][Full Text] [Related]
40. The missense Thr211Pro mutation in the factor X activation peptide of a bleeding patient causes molecular defect in the clotting cascade.
Ding Q; Shen Y; Yang L; Wang X; Rezaie AR
Thromb Haemost; 2013 Jul; 110(1):53-61. PubMed ID: 23677006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
